THE DIAGNOSTIC VALUE OF LUGOL 3% STAINING IN ORAL EPITHELIAL DYSPLASIA AND ORAL MUCOSAL CARCINOMA

Chi Nguyễn Thị Kim, Thủy Lê Thanh, Tuyến Võ Đắc

Main Article Content

Abstract

Objectives: The mortality rate of oral mucosal carcinoma is closely related to the time of detection. However, early diagnosis can be challenging due to the often-vague symptoms of the lesions in these initial stages.  Objective: This study aims to evaluate the diagnostic value of Lugol 3% staining in identifying dysplastic lesions and oral mucosal carcinoma (OMC). Materials and methods: 89 patients visited Ho Chi Minh City Oncology Hospital from April 2023 to April 2024 with oral mucosal lesions clinically diagnosed as potentially malignant disorders or suspected cancer and underwent biopsy for histopathology examination. Results: There were 16 cases clinically diagnosed as oral potentially malignant disorder (18%), and 73 cases suspected of having cancer (82%). The application of Lugol 3% staining demonstrated promising diagnostic potential for dysplasia and OMC, with a sensitivity of 89.9%, specificity of 70.0%, positive predictive value of 91.2%, and negative predictive value of 66.7%. However, clinical factors such as lesion site and type could influence test outcomes, necessitating cautious visual interpretation. Conclusion: With its simplicity, non-invasive nature, safety, and high sensitivity, Lugol 3% staining of the oral mucosa appears feasible for widespread implementation in OMC screening programs in Vietnam.

Article Details

References

1. Chaudhari A, Hegde-Shetiya S, Shirahatti R, Agrawal D. Comparison of different screening methods in estimating the prevalence of precancer and cancer amongst male inmates of a jail in maharashtra, India. Asian Pac J Cancer Prev. 2013;14(2): 859-864. doi:10.7314/ apjcp.2013.14.2.859
2. Elimairi I, Altay MA, Abdoun O, et al. Clinical relevance of the utilization of vital Lugol’s iodine staining in detection and diagnosis of oral cancer and dysplasia. Clin Oral Invest. 2017;21(2):589-595. doi:10.1007/s00784-016-1925-x
3. Epstein JB, Scully C, Spinelli J. Toluidine blue and Lugol’s iodine application in the assessment of oral malignant disease and lesions at risk of malignancy. Journal of Oral Pathology & Medicine. 1992;21(4): 160-163. doi:10.1111/j.1600-0714. 1992.tb00094.x
4. Isacsson G, Shear M. Content and distribution of glycogen in oral epithelial dysplasia. Scand J Dent Res. 1981;89(1):79-88. doi:10.1111/j.1600-0722.1981.tb01280.x
5. Maeda K, Suzuki T, Ooyama Y, et al. Colorimetric analysis of unstained lesions surrounding oral squamous cell carcinomas and oral potentially malignant disorders using iodine. International Journal of Oral and Maxillofacial Surgery. 2010;39(5):486-492. doi:10.1016/j.ijom. 2009.11.001
6. Neville BW, Damm DD, Allen CM, Chi AC. Epithelial Pathology. Neville BW, Damm DD, Allen CM, Chi AC. eds. Oral and Maxillofacial Pathology. 5th ed. Elsevier Health Sciences; 2023:401-421.
7. Sudheendra U, Sreeshyla H, Shashidara R. Vital tissue staining in the diagnosis of oral precancer and cancer: Stains, technique, utility, and reliability. Clinical Cancer Investigation Journal. 2014;3(2-2014): 141-145. doi:10.4103/ 2278-0513.130156
8. Thirunavukarasu S, Mathew P, Austin RD, Srivastava KC, Ramasamy S, Usha V. Efficacy of toluidine blue, lugol’s iodine and acetic acid for detecting oral lesions of Leukoplakia and erosive lichen planus – A cross-sectional study. Journal of Indian Academy of Oral Medicine and Radiology. 2020; 32(3): 253. doi:10.4103/jiaomr.jiaomr_ 22_20